The current financial score of Phibro Animal Health Corp is 8.39. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 396.75M, representing a year-over-year increase of 4.77%, while its net profit experienced a year-over-year increase of 26.05%.
The current valuation score of Phibro Animal Health Corp is 9.07. Its current P/E ratio is 14.52, which is 2488.28% below the recent high of 375.69 and 27.68% above the recent low of 10.50.
The current earnings forecast score of Phibro Animal Health Corp is 6.00. The average price target is 41.25, with a high of 49.00 and a low of 35.00.
The current price momentum score of Phibro Animal Health Corp is 3.53. Currently, the stock price is trading between the resistance level at 38.48 and the support level at 31.90, making it suitable for range-bound swing trading.
The current institutional shareholding score of Phibro Animal Health Corp is 10.00. The latest institutional shareholding proportion is 104.57%, representing a quarter-over-quarter increase of 7.05%. The largest institutional shareholder is John Hussman, holding a total of 42.00K shares, representing 0.30% of shares outstanding, with 53.42% decrease in holdings.
The current risk assessment score of Phibro Animal Health Corp is 6.77. The company's beta value is 0.50. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.